Statistical Analysis and Reporting

This contract involves performing comprehensive statistical analysis of clinical data for the FDA, specifically focusing on managing outliers, validating models, and preparing both interim and final reports in accordance with pre-established methodologies suitable for FDA submission. The work is designated as a subcontract under the NAICS code 541620, indicating professional scientific and technical services. The contract was posted on June 8, 2026, with a response deadline of July 6, 2026. The contract is issued by the FDA Office of Acquisition and Grant Services, part of the Department of Health and Human Services, with the place of performance located in Silver Spring, Maryland, zip code 20993. Although some organizational and contact details are unspecified, the key deliverables emphasize rigorous statistical scrutiny and documentation to support regulatory submissions, ensuring data integrity and compliance with FDA requirements.